Melanoma addiction to the long non-coding RNA SAMMSON
- PMID: 27008969
- DOI: 10.1038/nature17161
Melanoma addiction to the long non-coding RNA SAMMSON
Abstract
Focal amplifications of chromosome 3p13-3p14 occur in about 10% of melanomas and are associated with a poor prognosis. The melanoma-specific oncogene MITF resides at the epicentre of this amplicon. However, whether other loci present in this amplicon also contribute to melanomagenesis is unknown. Here we show that the recently annotated long non-coding RNA (lncRNA) gene SAMMSON is consistently co-gained with MITF. In addition, SAMMSON is a target of the lineage-specific transcription factor SOX10 and its expression is detectable in more than 90% of human melanomas. Whereas exogenous SAMMSON increases the clonogenic potential in trans, SAMMSON knockdown drastically decreases the viability of melanoma cells irrespective of their transcriptional cell state and BRAF, NRAS or TP53 mutational status. Moreover, SAMMSON targeting sensitizes melanoma to MAPK-targeting therapeutics both in vitro and in patient-derived xenograft models. Mechanistically, SAMMSON interacts with p32, a master regulator of mitochondrial homeostasis and metabolism, to increase its mitochondrial targeting and pro-oncogenic function. Our results indicate that silencing of the lineage addiction oncogene SAMMSON disrupts vital mitochondrial functions in a cancer-cell-specific manner; this silencing is therefore expected to deliver highly effective and tissue-restricted anti-melanoma therapeutic responses.
Comment in
-
SAMMSON Long Noncoding RNA Is Essential for Melanoma Cell Viability.Cancer Discov. 2016 May;6(5):470. doi: 10.1158/2159-8290.CD-RW2016-062. Epub 2016 Apr 7. Cancer Discov. 2016. PMID: 27056832
-
Targeting the lncRNA SAMMSON Reveals Metabolic Vulnerability in Melanoma.Cancer Cell. 2016 May 9;29(5):619-621. doi: 10.1016/j.ccell.2016.04.010. Cancer Cell. 2016. PMID: 27165740
-
Long non-coding RNA expression profiling in the NCI60 cancer cell line panel using high-throughput RT-qPCR.Sci Data. 2016 Jul 5;3:160052. doi: 10.1038/sdata.2016.52. Sci Data. 2016. PMID: 27377824 Free PMC article.
Similar articles
-
The oncogenic role of SAMMSON lncRNA in tumorigenesis: A comprehensive review with especial focus on melanoma.J Cell Mol Med. 2023 Dec;27(24):3966-3973. doi: 10.1111/jcmm.17978. Epub 2023 Sep 29. J Cell Mol Med. 2023. PMID: 37772815 Free PMC article. Review.
-
LncRNA SAMMSON Mediates Adaptive Resistance to RAF Inhibition in BRAF-Mutant Melanoma Cells.Cancer Res. 2021 Jun 1;81(11):2918-2929. doi: 10.1158/0008-5472.CAN-20-3145. Epub 2021 Mar 18. Cancer Res. 2021. PMID: 34087780
-
Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma.Nature. 2005 Jul 7;436(7047):117-22. doi: 10.1038/nature03664. Nature. 2005. PMID: 16001072
-
Targeting the lncRNA SAMMSON Reveals Metabolic Vulnerability in Melanoma.Cancer Cell. 2016 May 9;29(5):619-621. doi: 10.1016/j.ccell.2016.04.010. Cancer Cell. 2016. PMID: 27165740
-
Microphthalmia-associated transcription factor in melanoma development and MAP-kinase pathway targeted therapy.Pigment Cell Melanoma Res. 2015 Jul;28(4):390-406. doi: 10.1111/pcmr.12370. Epub 2015 Apr 17. Pigment Cell Melanoma Res. 2015. PMID: 25818589 Free PMC article. Review.
Cited by
-
Long Non-coding RNAs in the Regulation of the Immune Response and Trained Immunity.Front Genet. 2020 Jul 24;11:718. doi: 10.3389/fgene.2020.00718. eCollection 2020. Front Genet. 2020. PMID: 32793280 Free PMC article. No abstract available.
-
LncRNA PART1 Promotes Proliferation and Migration, Is Associated with Cancer Stem Cells, and Alters the miRNA Landscape in Triple-Negative Breast Cancer.Cancers (Basel). 2021 May 27;13(11):2644. doi: 10.3390/cancers13112644. Cancers (Basel). 2021. PMID: 34072264 Free PMC article.
-
LncRNA ASB16-AS1 Promotes Growth And Invasion Of Hepatocellular Carcinoma Through Regulating miR-1827/FZD4 Axis And Activating Wnt/β-Catenin Pathway.Cancer Manag Res. 2019 Nov 7;11:9371-9378. doi: 10.2147/CMAR.S220434. eCollection 2019. Cancer Manag Res. 2019. Retraction in: Cancer Manag Res. 2022 Feb 10;14:501-502. doi: 10.2147/CMAR.S361002 PMID: 31807066 Free PMC article. Retracted.
-
LncRNAs as Chromatin Regulators in Cancer: From Molecular Function to Clinical Potential.Cancers (Basel). 2019 Oct 10;11(10):1524. doi: 10.3390/cancers11101524. Cancers (Basel). 2019. PMID: 31658672 Free PMC article. Review.
-
Translation regulation in skin cancer from a tRNA point of view.Epigenomics. 2019 Feb;11(2):215-245. doi: 10.2217/epi-2018-0176. Epub 2018 Dec 19. Epigenomics. 2019. PMID: 30565492 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Associated data
- Actions
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous